METASTATIC MUCOSAL MELANOMA
Clinical trials for METASTATIC MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made vaccine trial targets advanced cancers
Disease control Recruiting nowThis early-stage study is testing a personalized vaccine designed to train the immune system to attack a patient's specific cancer. It is for adults with advanced breast cancer, melanoma, or non-small cell lung cancer that has continued to grow despite standard treatments. The ma…
Matched conditions: METASTATIC MUCOSAL MELANOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Could a morning shot fight cancer better?
Disease control Recruiting nowThis study is testing whether giving two immunotherapy drugs (ipilimumab and nivolumab) at specific times of day improves how well they work for advanced melanoma. Researchers want to see if receiving treatment in the morning, afternoon, or late afternoon leads to better survival…
Matched conditions: METASTATIC MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Brain battle: two drug cocktails face off against deadly melanoma spread
Disease control Recruiting nowThis trial is testing which of two drug combinations works better for people with advanced melanoma that has spread to the brain. One group gets three drugs (encorafenib, binimetinib, nivolumab), while the other gets two drugs (ipilimumab, nivolumab). The main goal is to see whic…
Matched conditions: METASTATIC MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC